January 18, 2023 11:21 AM ESTUpdated 02:20 PM
Startups
Deals
Pharma

Am­gen ex­tends au­toim­mune pact with small Michi­gan biotech

Kyle LaHucik

Senior Reporter

Am­gen is go­ing all in on a three-in­di­ca­tion col­lab­o­ra­tion with an Ann Ar­bor, MI biotech.

The Cal­i­for­nia phar­ma has elect­ed to move for­ward with all …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times